Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 11 - 20 of 146

Insights

At Recipharm, we are dedicated to supporting our customers when they need it most, particularly in these testing times since the outbreak of COVID-19. We are aware that our customers need to work quickly and efficiently, and the current travel restrictions that are in place create many challenges.

Insights

Unmet patient needs and ongoing advances in science and technology are the growth engines behind inhalation therapy.

Insights

Given the prevalence of the COVID-19 virus, Recipharm has been experiencing an increase in demand for antibiotic production. With the current climate, the supply of antibiotics is especially important as secondary bacterial infections are very common in severely ill COVID-19 patients.

Insights

Third party providers offer both the infrastructure and breadth of experience to help clients arrange testing programmes that are relevant, cost-effective and as streamlined as possible.

Insights

Multiple API products can offer improved efficacy while avoiding the need for patients to administer several drugs from different devices.

Insights

The UK’s official exit from the EU on January 31st marked the start of a year-long transition period, with a temporary deal agreed with the EU to keep the terms of trade relatively stable, at least for now.

Insights

In recent years, there have been many changes within the pharmaceutical industry that have influenced a surge in demand for CDMOs.

Insights

A CDMO with inhalation development experience will understand the intricacies involved with and the unique requirements of the development pathway.

Insights

With a central focus on human safety, high quality standards for drug products are upheld worldwide through various drug agencies.

Insights

Understanding regional differences, implementing best-practice documentation processes key to successful approval outcomes